Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00445471

A Prospective Study Comparing the Mifne Approach of Treating Childhood Autism With Routine Standard Treatment

Child Development Disorders, Pervasive Clinical Trial

Clinical Trial Summary

The current study aims at comparing outcomes achieved using the Mifne approach of treating autistic children with results obtained when routine standard treatment is used. A prospective comparative study will be performed comparing the results of 12 children treated at Mifne with 12 children treated with treatment as usual. A child and adolescent psychiatrist using the Autism Diagnostic Interview-Revised (ADI-R) and the Autism Diagnostic Observation Schedule-Generic (ADOS-G) will make the diagnostic assessment and a developmental psychologist will make the developmental and psychological assessments using the Vineland Adaptive Behavior Scales-Revised and the Bayley Scales of Infant Development (BSID II) before the child enters the study. Each child will be reassessed following completion of the Mifne intervention, at three and at six months after commencement of treatment. The control child will also be reassessed at three and at six months after commencement of a therapeutic intervention.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00445471
Study type Interventional
Source Rabin Medical Center
Contact
Status Terminated
Phase N/A
Start date April 2007
Completion date December 2012
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03222375 - SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism N/A
Completed NCT01233414 - Randomized Trial of Parent Training for Young Children With Autism N/A
Completed NCT00926471 - Social Skills and Anxiety Reduction Treatment for Children and Adolescents With Autism Spectrum Disorders Phase 1
Withdrawn NCT00376194 - Mercury Chelation to Treat Autism Phase 2
Completed NCT02153203 - Using the Prevent-Teach-Reinforce Model to Reduce Problem Behaviors in Children With Autism Spectrum Disorders N/A
Completed NCT02301195 - Trial of Therapeutic Horseback Riding in Children and Adolescents With Autism Spectrum Disorder N/A
Completed NCT00453180 - A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders Phase 2
Completed NCT04475848 - A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO6953958 in Healthy Participants Phase 1
Terminated NCT01517126 - Assessing Suicide Risk in Adolescents With Developmental Delays
Completed NCT00080145 - RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders N/A
Completed NCT00166595 - Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD) Phase 1/Phase 2
Completed NCT02124720 - Using Mobile Technology to Reduce Stereotypy N/A
Completed NCT01731119 - Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents Phase 2
Completed NCT00147394 - Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD) Phase 1
Completed NCT01921244 - Shared Decision Making to Improve Care and Outcomes for Children With Autism N/A
Completed NCT05688319 - Effect of Problem-Solving Training N/A
Active, not recruiting NCT00110708 - Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism Phase 2